Paper39113804
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries.
Yu HP and 5 others. Theranostics, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries. Papers, record 39113804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39113804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sepsis | Major topic |
| Nucleic Acids | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Animals | |
| Genetic Therapy | |
| Multiple Organ Failure | |
| Gene Transfer Techniques |
Source PubMed
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36328633 | Cytokine Release Syndrome and Sepsis: Analogous Clinical Syndromes with Distinct Causes and Challenges in Management. | Infect Dis Clin North Am | 2022 | https://conductscience.org/library/papers/36328633 | PubMed |
| 2 | 30194660 | Review: the Role and Mechanisms of Macrophage Autophagy in Sepsis. | Inflammation | 2019 | https://conductscience.org/library/papers/30194660 | PubMed |
| 3 | 22970170 | A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. | PLoS One | 2012 | https://conductscience.org/library/papers/22970170 | PubMed |
| 4 | 32593642 | Recent advancements in liposome technology. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32593642 | PubMed |
| 5 | 38147783 | Nanomaterial-based methods for sepsis management. | Enzyme Microb Technol | 2024 | https://conductscience.org/library/papers/38147783 | PubMed |
| 6 | 36183679 | HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/36183679 | PubMed |
| 7 | 28117397 | Sepsis and septic shock. | Nat Rev Dis Primers | 2016 | https://conductscience.org/library/papers/28117397 | PubMed |
| 8 | 35060376 | Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35060376 | PubMed |
| 9 | 24707934 | Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis. | Am J Respir Crit Care Med | 2014 | https://conductscience.org/library/papers/24707934 | PubMed |
| 10 | 30118853 | Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy. | Acta Biomater | 2018 | https://conductscience.org/library/papers/30118853 | PubMed |
| 11 | 36555120 | The Role of microRNAs in Inflammation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555120 | PubMed |
| 12 | 37351162 | Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis. | Theranostics | 2023 | https://conductscience.org/library/papers/37351162 | PubMed |
| 13 | 21304987 | Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. | PLoS One | 2011 | https://conductscience.org/library/papers/21304987 | PubMed |
| 14 | 36317129 | Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease. | JACC Basic Transl Sci | 2022 | https://conductscience.org/library/papers/36317129 | PubMed |
| 15 | 36499287 | Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499287 | PubMed |
| 16 | 34834316 | miRNA Delivery by Nanosystems: State of the Art and Perspectives. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834316 | PubMed |
| 17 | 38200360 | The critically ill older patient with sepsis: a narrative review. | Ann Intensive Care | 2024 | https://conductscience.org/library/papers/38200360 | PubMed |
| 18 | 36820059 | An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/36820059 | PubMed |
| 19 | 24361371 | Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury. | J Control Release | 2014 | https://conductscience.org/library/papers/24361371 | PubMed |
| 20 | 35122598 | miR-126 ameliorates multiple organ dysfunction in septic rats by regulating the differentiation of Th17/Treg. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35122598 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723083 | Epigenetic regulation of neutrophil dysfunction in sepsis: mechanisms, biomarkers, and translational challenges. | J Transl Med | 2026 | https://conductscience.org/library/papers/42723083 | PubMed |
| 42491566 | Decoding cardiorenal crosstalk: Intercellular communication mechanisms and therapeutic insights in cardiorenal syndrome. | iScience | 2026 | https://conductscience.org/library/papers/42491566 | PubMed |
| 42338897 | Stimuli-Responsive Nanocarriers for Transdermal siRNA Delivery: Mechanisms, Challenges, and Therapeutic Strategies. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42338897 | PubMed |
| 42094210 | The Regulatory Landscape of Ferroptosis and Iron Homeostasis: Pathophysiological Mechanisms and Therapeutic Horizons in Cardiovascular Disease. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42094210 | PubMed |
| 42079437 | Decoy Nanoparticles and Protein Corona Modulation: A Novel Frontier in Sepsis Treatment. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42079437 | PubMed |
| 42010558 | mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42010558 | PubMed |
| 41809891 | Biomaterials-mediated sequential drug delivery: Emerging trends for wound healing. | Asian J Pharm Sci | 2025 | https://conductscience.org/library/papers/41809891 | PubMed |
| 41803155 | DPEP2 suppresses hyperinflammation via metabolic reprogramming of macrophages in sepsis. | Nat Commun | 2026 | https://conductscience.org/library/papers/41803155 | PubMed |
| 41452346 | The role of immunomodulatory nano systems in the treatment of sepsis: past, present, and future. | Nanomedicine (Lond) | 2026 | https://conductscience.org/library/papers/41452346 | PubMed |
| 41233191 | GDF15 nanotherapy ameliorates NLRP3-associated redox imbalance and cardiac injury in sepsis. | Redox Biol | 2025 | https://conductscience.org/library/papers/41233191 | PubMed |
| 40590921 | Eupatilin modulates the Mcl-1 ubiquitination status and PI3K/Akt/Foxo3a pathway to inhibit apoptosis and alleviate sepsis-induced acute myocardial injury. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40590921 | PubMed |
| 39694526 | [Research progress on the role of ferroptosis in aortic dissection]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/39694526 | PubMed |
| 39483479 | Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery. | Front Immunol | 2024 | https://conductscience.org/library/papers/39483479 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39113804
GET https://conductscience.org/api/papers/v1/39113804/references?page=2